A movement disorder specialist at Northwestern Medicine discussed developments in disease-modifying research, adaptive clinical trial designs, and evolving device-based therapies in Parkinson disease. [WATCH TIME: 5 minutes]
Mariana Hernandez Gonzalez-Monje, MD, PhD
Advertisement
Movement disorder specialist at Northwestern Medicine.
Articles by Mariana Hernandez Gonzalez-Monje, MD, PhD
Neurology experts highlighted ongoing developments in artificial intelligence applications, disease-modifying mechanisms, and genetic therapies expected to undergo evaluation. [WATCH TIME: 9 minutes]
Advertisement
Latest Updated Articles
Look Ahead in Neurology: What are Clinicians Excited About for 2026?February 17th 2026
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Current Treatment Strategies for Dravet Syndrome
2
NeurologyLive®'s Conference Coverage, Oveporexton Displays Symptom Improvement in NT1, FDA Allows BLA for AMT-130 in HD
3
Beyond Motor Symptoms: The Power of Connection in Parkinson Disease
4
FDA Allows AMT-130 Huntington Disease Data to Support Planned BLA Submission Under Accelerated Approval Pathway
5